joyce o’shaughnessy, md, on differentiating cdk4/6 inhibitors
Published 5 years ago • 196 plays • Length 1:28
Download video MP4
Download video MP3
Similar videos
-
1:30
joyce o’shaughnessy, md, on the role of cdk4/6 inhibitors in the management of tnbc
-
2:27
dr. o’shaughnessy on differentiating between cdk 4/6 inhibitors
-
2:04
dr. joyce o’shaughnessy on promising agents in triple-negative breast cancer
-
2:31
cdk4/6 inhibitor toxicity management
-
0:49
joyce o’shaughnessy, md, shares relevant findings from the monarch-2 trial
-
6:17
when to choose chemotherapy vs cdk4/6 inhibitors
-
1:09
joyce o’shaughnessy, md, shares results of the impassion130 trial presented at esmo 2019
-
0:35
joyce o'shaughnessy, md on the sobo mid-year update webcast
-
1:04
dr. joyce o'shaughnessy invites you the international congress on the future of breast cancer
-
7:22
future of cdk4/6 inhibition in hr breast cancer
-
1:02
joyce o’shaughnessy, md, elaborates on the monaleesa-3 trial presented at esmo 2019
-
19:30
empowering choices: navigating early-stage hr , her2- breast cancer with cdk4/6 inhibition
-
1:22
dr. o'shaughnessy on the utility of capivasertib in targeting akt in breast cancer
-
0:56
joyce o'shaughnessy, md explains the importance of the school of breast oncology
-
1:56
joyce o’shaughnessy, md: treatment goals for patients with tnbc and multiple metastatic sites
-
0:58
joyce o’shaughnessy, md: third-line options to prolong life
-
6:38
molecular re-classification of breast cancer – part 2: joyce o'shaughnessy
-
1:47
dr. joyce o'shaughnessy on treatment with everolimus in advanced breast cancer
-
2:08
dr. joyce o'shaughnessy on eribulin in metastatic breast cancer
Clip.africa.com - Privacy-policy